IP Library Granted Patent US 9,371,470
Granted Patent B2
US 9,371,470 · App. 14/333,921 · Granted Jun 21, 2016

Two part-cyanoacrylate/free radically curable adjesive systems

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,371,470
App. No.
14/333,921
Granted
Jun 21, 2016
Kind
B2
Abstract

Two part cyanoacrylate/free radical curable adhesive systems, are provided.

Claims (16)

1. A two part curable composition comprising:

(a) a first part comprising a cyanoacrylate component and t-butyl perbenzoate as a peroxide catalyst present in an amount from about 0.01% to about 10%, by weight of the cyanoacrylate component; and

(b) a second part comprising a free radical curable component and a transition metal,

wherein the cyanoacrylate component comprises H 2 C═C(CN)—COOR, wherein R is selected from alkyl, alkoxyalkyl, cycloalkyl, alkenyl, aralkyl, aryl, allyl and haloalkyl groups, and wherein when mixed together the peroxide catalyst initiates cure of the free radical curable component and the transition metal initiates cure of the cyanoacrylate component.

2. The composition of claim 1 , wherein at least one of the first part or the second part further comprises an organic acid having a pK a of about 12 or less.

3. The composition of claim 1 , wherein the free radical curable component is selected from a (meth)acrylate component, maleimide-, itaconamide- or nadimide-containing compounds, and combinations thereof.

4. The composition of claim 1 , wherein the free radical curable component is a (meth)acrylate component selected from the group consisting of polyethylene glycol di(meth)acrylates, tetrahydrofuran (meth)acrylates and di(meth)acrylates, hydroxypropyl (meth)acrylate, hexanediol di(meth)acrylate, trimethylol propane tri(meth)acrylate, diethylene glycol dimethacrylate, triethylene glycol dimethacrylate, benzylmethacrylate, tetraethylene glycol dimethacrylate, dipropylene glycol dimethacrylate, di-(pentamethylene glycol) dimethacrylate, tetraethylene diglycol diacrylate, diglycerol tetramethacrylate, tetramethylene dimethacrylate, ethylene dimethacrylate, neopentyl glycol diacrylate, trimethylol propane triacrylate and bisphenol-A mono and di(meth)acrylates.

5. The composition of claim 1 , wherein the transition metal comprises a member selected from the group consisting of copper, vanadium, cobalt and iron.

6. The composition of claim 1 , wherein the first part is housed in a first chamber of a dual chamber syringe and the second part is housed in a second chamber of the dual chamber syringe.

7. The composition of claim 1 , wherein the second part further comprises at least one of a plasticizer, a filler and a toughener.

8. The composition of claim 6 , wherein the toughener is a member selected from the group consisting of (a) reaction products of the combination of ethylene, methyl acrylate and monomers having carboxylic acid cure sites, (b) dipolymers of ethylene and methyl acrylate, (c) combinations of (a) and (b), (4) vinylidene chloride-acrylonitrile copolymers, (5) and vinyl chloride/vinyl acetate copolymer, (6) copolymers of polyethylene and polyvinyl acetate, and combinations thereof.

9. The composition of claim 1 , wherein the first part and the second part are present in a ratio of about 1:1 by volume.

10. The composition of claim 1 , wherein the first part and the second part are each housed in a separate chamber of a dual chambered container.

11. The composition of claim 2 , wherein at least one of the first part or the second part further comprises a member selected from the group consisting of sulfimides, sulfonamides, citric acid, maleic acid, succinic acid, phthalic acid, di-carboxylic acid, maleic anhydride, maleic dianhydride, succinic anhydride, phthalic anhydride, and combinations thereof.

12. The composition of claim 4 , wherein the free radical curable component is a (meth)acrylate component selected from the group consisting of ethoxylated bisphenol-A (meth)acrylate, ethoxylated bisphenol-F (meth)acrylate, methacrylate-functional urethanes, and combinations thereof.

13. The composition of claim 5 , wherein the transition metal comprises copper in the form of a member selected from the group consisting of copper (II) 3,5-diisopropylsalicylate hydrate, copper bis(2,2,6,6-tetramethyl-3,5-heptanedionate), copper (II) hydroxide phosphate, copper (II) chloride, copper (II) acetate monohydrate, tetrakis(acetonitrile)copper (I) hexafluorophosphate, copper (II) formate hydrate, tetrakisacetonitrile copper (I) triflate, copper(II)tetrafluoroborate, copper (II) perchlorate, tetrakis(acetonitrile)copper (I) tetrafluoroborate, copper (II) hydroxide, copper (II) hexafluoroacetylacetonate hydrate and copper (II) carbonate.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2022
From: HENKEL IP & HOLDING GMBH
To: HENKEL AG & CO. KGAA
Reel/Frame 059357/0267 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2016
From: BARNES, RORY B.; BURNS, BARRY N.; WIGHAM, JONATHAN P.; HERSEE, RACHEL M.; WARD, EMER
To: HENKEL IRELAND LIMITED
Reel/Frame 037882/0559 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2016
From: HENKEL AG & CO. KGAA
To: HENKEL IP & HOLDING GMBH
Reel/Frame 037883/0044 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2016
From: HENKEL IRELAND LIMITED
To: HENKEL AG & CO. KGAA
Reel/Frame 038037/0983 →